Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Gene Expression Profiling Reveals 5-Azacytidine to Be a Novel, Potentially Effective Therapy for Poor-Prognosis Patients with Multiple Myeloma.

Sascha Tuchman, MD, Chaitanya Acharya, William Mostertz, William Barry, PhD, Cristina Gasparetto, MD, Bart Barlogie, MD, PhD, Anil Potti, M.D., John D Shaughnessy, Jr., Ph.D.

Blood (2009) 114 (22): 1833.

https://doi.org/10.1182/blood.V114.22.1833.1833

Published: 2009

Journal Articles

Gene Expression Profiles with Signatures of Tumor Biology and Chemotherapy Sensitivity May Provide a Novel Approach to Maximize Response to Induction Therapy in Patients with Acute Myeloid Leukemia.

Arati V Rao, Sascha A Tuchman, Anil Potti, David A. Rizzieri, MD, Hiroyuki Mano, Ruud Delwel, PhD, Peter Valk, B. Lowenberg, MD

Blood (2008) 112 (11): 2252.

https://doi.org/10.1182/blood.V112.11.2252.2252

Published: 2008

Journal Articles

Whole Blood Gene Expression Profiles Distinguish Patients with Single Prior Venous Thromboembolism from Patients with Multiple Prior Events.

Olga M. Akay, MD, Lulit Price, Holly Dressman, PhD, Deborah Lewis, PhD, Anil Potti, MD, Jen-Tsan Chi, MD, Thomas L. Ortel, MD, PhD

Blood (2007) 110 (11): 1630.

https://doi.org/10.1182/blood.V110.11.1630.1630

Published: 2007

Journal Articles

A Genomic Strategy To Refine Prognosis and Predict Response to Therapy in Chronic Lymphocytic Leukemia.

Daphne R. Friedman, MD, J. Brice Weinberg, MD, Anil Potti, MD, Alicia D. Volkheimer, Karen M. Bond, Youwei Chen, Ning Jiang, Joseph O. Moore, MD, Jon P. Gockerman, MD, Louis F. Diehl, MD, Carlos M. Decastro, MD, Joseph R. Nevins, PhD

Blood (2007) 110 (11): 3096.

https://doi.org/10.1182/blood.V110.11.3096.3096

Published: 2007

Journal Articles

Gene Expression Profiles for Prognosis in MGUS, Coupled with Signatures of Oncogenic Pathway Deregulation Provide a Novel Approach for Selection of Molecular Targets in Multiple Myeloma.

Ariel Anguiano, MD, Chaitanya Acharya, Kelly Salter, Daniel McCluskey, Christina Gasperetto, MD, Fenghuang Zhan, MD, Madhav Dhodapkar, PhD, Joseph Nevins, PhD, Bart Barlogie, MD, John D. Shaughnessy, Jr., PhD, Anil Potti, MD

Blood (2007) 110 (11): 655.

https://doi.org/10.1182/blood.V110.11.655.655

Published: 2007

Journal Articles

Gene Expression Patterns Identify Patients with Non-Small Cell Lung Cancer (NSCLC) and Ovarian Cancer Who Are at Increased Risk for Venous Thromboembolism (VTE).

Veshana S. Ramiah, MD, Anil Potti, MD, Rebecca Peterson, MD, David Harpole, MD, Andrew Berchuck, MD, Thomas L. Ortel, MD

Blood (2006) 108 (11): 1470.

https://doi.org/10.1182/blood.V108.11.1470.1470

Published: 2006

Journal Articles

Gene-expression patterns predict phenotypes of immune-mediated thrombosis

Anil Potti, Andrea Bild, Holly K. Dressman, Deborah A. Lewis, Joseph R. Nevins, Thomas L. Ortel

Blood (2006) 107 (4): 1391–1396.

https://doi.org/10.1182/blood-2005-07-2669

Published: 2006

Journal Articles

Gene Expression Patterns Identify Novel Biologically Relevant Signaling and Transcriptional Pathways Involved in Terminal Erythroid Differentiation and Polycythemia Vera.

Anil Potti, MBBS, Holly K. Dressman, PhD, Murat O. Arcasoy, MD

Blood (2005) 106 (11): 3524.

https://doi.org/10.1182/blood.V106.11.3524.3524

Published: 2005

Journal Articles

Peripheral Blood Mononuclear Cell Derived Gene Expression Patterns Identify Clinical Phenotypes and Predict Thrombotic Events in Patients with Immune-Mediated Thrombosis.

Anil Potti, Andrea Bild, Deborah A. Lewis, Holly Dressman, Joseph R. Nevins, Thomas L. Ortel

Blood (2005) 106 (11): 726.

https://doi.org/10.1182/blood.V106.11.726.726

Published: 2005

Journal Articles

A Novel Chemically Induced Fischer F344 Rat Model for Thrombotic Sequelae of Hemolytic Anemias.

Anil Potti, MD, Heather Hoke, Sandra Ward, Shyamal Peddada, PhD, Jogin Wu, PhD, Thomas L. Ortel, MD, PhD, Abraham Nyska, DVM

Blood (2004) 104 (11): 3519.

https://doi.org/10.1182/blood.V104.11.3519.3519

Published: 2004

NARROW

Gene Expression Profiling Reveals 5-Azacytidine to Be a Novel, Potentially Effective Therapy for Poor-Prognosis Patients with Multiple Myeloma.

Gene Expression Profiles with Signatures of Tumor Biology and Chemotherapy Sensitivity May Provide a Novel Approach to Maximize Response to Induction Therapy in Patients with Acute Myeloid Leukemia.

Whole Blood Gene Expression Profiles Distinguish Patients with Single Prior Venous Thromboembolism from Patients with Multiple Prior Events.

A Genomic Strategy To Refine Prognosis and Predict Response to Therapy in Chronic Lymphocytic Leukemia.

Gene Expression Profiles for Prognosis in MGUS, Coupled with Signatures of Oncogenic Pathway Deregulation Provide a Novel Approach for Selection of Molecular Targets in Multiple Myeloma.

Gene Expression Patterns Identify Patients with Non-Small Cell Lung Cancer (NSCLC) and Ovarian Cancer Who Are at Increased Risk for Venous Thromboembolism (VTE).

Gene-expression patterns predict phenotypes of immune-mediated thrombosis

Gene Expression Patterns Identify Novel Biologically Relevant Signaling and Transcriptional Pathways Involved in Terminal Erythroid Differentiation and Polycythemia Vera.

Peripheral Blood Mononuclear Cell Derived Gene Expression Patterns Identify Clinical Phenotypes and Predict Thrombotic Events in Patients with Immune-Mediated Thrombosis.

A Novel Chemically Induced Fischer F344 Rat Model for Thrombotic Sequelae of Hemolytic Anemias.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only